The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Barwell Plc, startups are often financed by Tweed Renaissance Investors Capital, Scottish Investment Bank, Archangels. The meaningful sponsors for the fund in investment in the same round are Tweed Renaissance Investors Capital, Scottish Investment Bank, Archangels. In the next rounds fund is usually obtained by Tweed Renaissance Investors Capital, Scottish Investment Bank, Archangels.
The important activity for fund was in 2013. The fund is generally included in less than 2 deals every year. The usual things for fund are deals in the range of 1 - 5 millions dollars.
Among the various public portfolio startups of the fund, we may underline Lamellar Biomedical, MGB Biopharma Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most successful fund investment fields, there are Telecommunications, Manufacturing.
| Fund Name | Location |
| A+E Networks | New York, New York, United States |
| Aipu Yiyao Touzi | China, Fujian, Hunan |
| Astrec Baltic | Estonia, Harjumaa, Tallinn |
| Caufield Angel Fund | - |
| CJ Cheiljedang | - |
| Ganot Capital | Florida, Hollywood, United States |
| Grant | - |
| Guangzhou Zexian Touzi Hehuo Qiye | - |
| Hatch Ventures | British Columbia, Canada, Vancouver |
| Lufthansa Cargo | Frankfurt, Germany, Hessen |
| Mercedes-Benz Research and Development India | Bengaluru, India, Karnataka |
| Mission Bay Capital | California, San Francisco, United States |
| MOBILE WORLD CAPITAL | Barcelona, Catalonia, Spain |
| Plug and Play Japan | Japan, Tokyo |
| Shanghai Resource Property | China, Shanghai |
| Shenwan Hongyuan | China, Shanghai |
| Spruce Capital Partners | California, San Francisco, United States |
| TAO Investments | Derby, England, United Kingdom |
| Vocap Ventures | Atlanta, Georgia, United States |
| Yuanxi Capital | China, Guangdong, Shenzhen |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
MGB Biopharma | $6M | 17 Sep 2014 | Tonbridge and Malling, England, United Kingdom | ||
Connect-In Ltd | 30 Apr 2014 | Glasgow, Scotland, United Kingdom | |||
Lamellar Biomedical | $4M | 07 Jan 2013 | United Kingdom, Scotland, United Kingdom | ||
MGB Biopharma | $3M | 31 Mar 2010 | Tonbridge and Malling, England, United Kingdom | ||
Factonomy | $1M | 30 May 2008 | United Kingdom, Scotland, United Kingdom |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
MGB Biopharma | $6M | 17 Sep 2014 | Tonbridge and Malling, England, United Kingdom | ||
Connect-In Ltd | 30 Apr 2014 | Glasgow, Scotland, United Kingdom | |||
Lamellar Biomedical | $4M | 07 Jan 2013 | United Kingdom, Scotland, United Kingdom | ||
MGB Biopharma | $3M | 31 Mar 2010 | Tonbridge and Malling, England, United Kingdom | ||
Factonomy | $1M | 30 May 2008 | United Kingdom, Scotland, United Kingdom |
